Cargando…
Interferon gamma runs interference on persistent COVID-19
COVID-19 represents a collection of disease endotypes stemming from infection with SARS-CoV-2 and thus requires precision medicine approaches to target specific viral variants and stages of illness. In this issue, van Laarhoven et al.(1) describe five immunocompromised patients with prolonged COVID-...
Autores principales: | Elliott, Eric Isaac, Wang, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500527/ https://www.ncbi.nlm.nih.gov/pubmed/34661183 http://dx.doi.org/10.1016/j.medj.2021.09.004 |
Ejemplares similares
-
COVID-19 and emerging viral infections: The case for interferon lambda
por: Prokunina-Olsson, Ludmila, et al.
Publicado: (2020) -
Epigenetic and transcriptional control of interferon-β
por: Daman, Andrew W., et al.
Publicado: (2021) -
Quantifying exposure to running for meaningful insights into running-related injuries
por: Davis IV, John J, et al.
Publicado: (2019) -
Interpreting interest in interferon-α
por: Thibault, Donna L, et al.
Publicado: (2003) -
A Call to Action Against Persistent Lack of Transparency in Vaccine Pricing Practices During the COVID-19 Pandemic
por: Arguedas-Ramírez, Gabriela
Publicado: (2022)